Shijie Zhang

Dr. Shijie Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2018 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
SZShijie Zhang
Shijie Zhang
XZXiaoyun Zhang
Xiaoyun Zhang
QSQianqian Sun
Qianqian Sun
CZChunbo Zhuang
Chunbo Zhuang
GLGuanlin Li
Guanlin Li
HWHuaqi Wang
Huaqi Wang
Recently, long noncoding RNAs (lncRNAs) are attracting wide attention in the field of cancer research because of its important role in cancer diagnosis and prognosis. But studies on the biological effects and relevant mechanisms of lncRNAs in non‐small cell lung cancer (NSCLC) remain few and need to be enriched. Our study discussed the expression and biological effects of LncRNA NR2F2‐AS1, and further explored its possible molecular mechanisms. As a result, elevated expression of NR2F2‐AS1 was detected in NSCLC tissues and cells and was remarkably associated with the tumor, node, metastasis (TNM) stage and the status of lymphatic metastasis of patients. Down‐regulated NR2F2‐AS1 contributed to the promotion of cell apoptosis and the inhibition of cell proliferation and invasion in A549 and SPC‐A‐1 cells in vivo and vitro. Through bioinformatics analysis, NR2F2‐AS1 functions as a ceRNA directly binding to miR‐320b, BMI1 was a direct target of miR‐320b. Combined with the following cellular experiments, the data showed that NR2F2‐AS1 may influence the NSCLC cell proliferation, invasion and apoptosis through regulating miR‐320b targeting BMI1.

20 March 2014 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SZShijie Zhang
Shijie Zhang
JFJian-Fang Feng
Jian-Fang Feng
LWLei Wang
Lei Wang
WGWei Guo
Wei Guo
YDYu-Wen Du
Yu-Wen Du
GZGuoqiang Zhao
Guoqiang Zhao

20 March 2014 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
SZShijie Zhang
Shijie Zhang
LWLei Wang
Lei Wang
HLHongchun Liu
Hongchun Liu
GZGuoqiang Zhao
Guoqiang Zhao
LMLiang Ming
Liang Ming
Myricetin, a common dietary flavonoid is widely distributed in fruits and vegetables, and is used as a health food supplement based on its immune function, anti-oxidation, anti-tumor, and anti-inflammatory properties. The aim of this study was to investigate the effects of myricetin on combination with radiotherapy enhance radiosensitivity of lung cancer A549 and H1299 cells. A549 cells and H1299 cells were exposed to X-ray with or without myricetin treatment. Colony formation assays, CCK-8 assay, flow cytometry and Caspase-3 level detection were used to evaluate the radiosensitization activity of myricetin on cell proliferation and apoptosis in vitro. Nude mouse tumor xenograft model was built to assessed radiosensitization effect of myricetin in vivo. Compared with the exposed group without myricetin treatment, the groups treated with myricetin showed significantly suppressed cell surviving fraction and proliferation, increased the cell apoptosis and increased Caspase-3 protein expression after X-ray exposure in vitro. And in vivo assay, growth speed of tumor xenografts was significantly decreased in irradiated mice treated with myricetin. The study demonstrated both in vitro and in vivo evidence that combination of myricetin with radiotherapy can enhance tumor radiosensitivity of pulmonary carcinoma A549 and H1299 cells, and myricetin could be a potential radiosensitizer for lung cancer therapy. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/5791518001210633.

18 July 2014 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
LWLei Wang
Lei Wang
JFJianfang Feng
Jianfang Feng
XCXiaonan Chen
Xiaonan Chen
WGWei Guo
Wei Guo
YDYuwen Du
Yuwen Du
GZGuoqiang Zhao
Guoqiang Zhao
Flavonoids are structurally heterogeneous, polyphenolic compounds present in high concentrations in fruits, vegetables, and other plant-derived foods. Currently, there is growing interest in the therapeutic applications of bioflavonoids for the treatment and prevention of diseases in humans. Myricetin is a naturally occurring flavonoid that is commonly found in tea, berries, fruits, vegetables, and medicinal herbs. Previous studies have shown that myricetin has antioxidant, anti-inflammatory and potent anticancer effects. It was interesting to investigate whether myricetin has the cooperative inhibitory effect combined with 5-fluorouracil on esophageal cancer cells.